Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets

About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hormone replacement therapy (HRT), but estrogens in cur...

תיאור מלא

מידע ביבליוגרפי
Autores principales: Zuo, Qianying, Chen, Karen L., Arredondo Eve, Alicia, Liu, Yu-Jeh, Kim, Sung Hoon, Katzenellenbogen, Benita S., Katzenellenbogen, John A., Madak-Erdogan, Zeynep
פורמט: Online Artículo Texto
שפה:English
יצא לאור: MDPI 2021
נושאים:
Article
גישה מקוונת:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

אינטרנט

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

פריטים דומים